Logo

Syncom Formulations Share Price

Syncom Formulations (INR)18.08-0.8   (-4.3%)

Exchange ScripsBSE524470NSESYNCOMFISININE312C01025

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Syncom Formulations Performance

Market performance
Open price18.88
High18.94
Volumes3053380
Prev Close18.08
Low18
Closing date2025-01-10
Historical performance
1 Year High27.90
3 Year High27.90
5 Year High27.90
1 Year Low10.95
3 Year Low4.60
5 Year Low4.60

Syncom Formulations Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
1702
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
67.14
Dividend Yield
Dividend Yield
N/A

Syncom Formulations Investment Returns

1 Year
8.9%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Syncom Formulations Technicals

IndicatorsValueSignal
5-DMA19.11Bearish
10-DMA19.72Bearish
20-DMA20.24Bearish
50-DMA20.64Bearish
100-DMA21.02Bearish
200-DMA17.26Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters1313131313
Foreign Investors---------------
Domestic Investors1313131313
Public Investors469229376517325748289969224239
Government---------------

Syncom Formulations Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2017
Other Income13514612028
Operating Profit434345320193
Interest4734193
Depreciation47453931
Profit Before Tax340266262159
Consolidated Net Profit253201198105
Adjusted EPS------------

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2017
Share Capital940940862781
Total Reserves194116201309393
Minority Interest------------
Total Non-Current Liabilities100877877
Total Liabilities4047377830821839
Capital Work in Progress---256622
Total Assets4047377830821839

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2017
Cash Flow from Operating Activities-60105163138
Cash Flow from Investing Activities830-450-271-177
Cash Flow from Financing Activitie-1463508347
Net Cash Inflow / Outflow6256-248
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 67.14.
  • 3Y Stock Price CAGR of the stock is 49.4.
  • The stock has a beta of 1.0.
  • In the last financial year, the company had an EBITDA of ₹434 Million.
  • The company generated revenue of ₹2634 Million in the previous financial year.

Syncom Formulations

18.08-0.8   (-4.3%)

Investment Amount: ₹ 1590
Current Value: ₹ 1808
Performance: 13.7%
P/L: ₹ 218
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
AWL291.1(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month